高流量鼻カニューラ市場:製品別、患者タイプ別、用途別、エンドユーザー別、地域別 ― 2031年までの世界予測High Flow Nasal Cannula Market by Product, Patient Type, Application, End User, & Region - Global Forecast to 2031 高流量鼻カニューレ(HFNC)市場は、2026年の0.94億米ドルから、2031年までに1.44億米ドルに達すると予測されており、予測期間中の年平均成長率(CAGR)は8.9%となる見込みです。 HFNC市場は、急性および慢性... もっと見る
英語原文をAIを使って翻訳しています。
サマリー高流量鼻カニューレ(HFNC)市場は、2026年の0.94億米ドルから、2031年までに1.44億米ドルに達すると予測されており、予測期間中の年平均成長率(CAGR)は8.9%となる見込みです。 HFNC市場は、急性および慢性の呼吸器疾患による負担の増大、急性低酸素性呼吸不全の症例増加、ならびに非侵襲的呼吸支援への需要の高まりにより、成長を遂げています。 HFNCは、加温・加湿されたガスとともに、より信頼性の高い酸素供給、酸素化の改善、呼吸労作の軽減、上気道デッドスペースの洗浄、および分泌物の除去促進をもたらします。従来の酸素療法や一部のNIVと比較して、患者の快適性と耐容性が向上していることも、臨床現場でのより広範な採用を後押ししています。 さらに、集中治療室、救急部門、抜管後のケア、挿管前のプレオキシゲネーション、周術期管理、気管支鏡検査、およびNIVやCPAPの休止期間におけるHFNCの適用範囲の拡大が、市場の成長に寄与しています。 臨床現場での受容度の高まりや、新生児、小児、成人患者向けのHFNCシステムの入手可能性の向上により、医療現場全体での利用範囲はさらに広がりつつある。 用途別に見ると、急性呼吸不全分野が、高流量鼻カニューレ市場において最大のシェアを占めると推定されている。 エンドユーザー別に見ると、病院セグメントがハイフロー鼻カニューレ市場において最大のシェアを占めると推定される。 北米における高流量鼻カニューレ市場では、米国が最も高い年平均成長率(CAGR)を記録すると見込まれている。 本レポートで言及されている高流量鼻カニューレ市場の主要な参加者(供給側)の内訳は、以下の通りです。 高流量鼻カニューレ市場の主要企業には、フィッシャー・アンド・ペイケル・ヘルスケア・リミテッド(ニュージーランド)、ヴァポサーム(米国)、レスメド(米国)、ハミルトン・メディカルAG(スイス)、およびドレーガーヴェルクAG & Co. KGaA(ドイツ)などが挙げられる。 調査対象分野: 本レポートを購入すべき理由 本レポートでは、以下のポイントについて考察しています: 目次1 はじめに 25 2 エグゼクティブサマリー 29 3 プレミアムインサイト 34 4 市場概要 38 5 業界トレンド 53 6 技術の進歩、AIによる影響、特許、イノベーション、将来の用途 73 7 規制環境 91 8 顧客環境と購買行動 100 9 高流量鼻カニューラ市場、製品別 107 10 高流量鼻カニューラ市場、用途別 117 11 高流量鼻カニューラ市場、エンドユーザー別 124 12 高流量鼻カニューラ市場、患者タイプ別 131 13 高流量鼻カニューラ市場、地域別 137 14 競争環境 212 15 企業プロファイル 231 16 調査手法 271 17 付録 284 図表リストTABLE 1 HIGH FLOW NASAL CANNULA MARKET: INCLUSIONS AND EXCLUSIONS 26.TABLE 2 HIGH FLOW NASAL CANNULA MARKET: CURRENT UNMET NEEDS 44. TABLE 3 HIGH FLOW NASAL CANNULA MARKET: PORTER'S FIVE FORCES ANALYSIS 53. TABLE 4 GDP PERCENTAGE CHANGE, BY KEY COUNTRIES, 2021-2030 56. TABLE 5 AVERAGE SELLING PRICE TREND OF HFNC SYSTEM, BY KEY PLAYER, 2025 (USD) 62. TABLE 6 AVERAGE PRICING TREND OF HIGH FLOW NASAL CANNULA, BY REGION, 2023–2025 (USD) 63. TABLE 7 IMPORT DATA FOR HIGH FLOW NASAL CANNULA PRODUCTS (HS CODE 9019), BY COUNTRY, 2021–2025 (USD THOUSANDS) 63. TABLE 8 EXPORT DATA FOR HIGH FLOW NASAL CANNULA PRODUCTS (HS CODE 9019), BY COUNTRY, 2021–2025 (USD THOUSANDS) 64. TABLE 9 HIGH FLOW NASAL CANNULA MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS (2026–2027) 64. TABLE 10 US ADJUSTED RECIPROCAL TARIFF RATES 68. TABLE 11 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR HIGH FLOW NASAL CANNULA 69. TABLE 12 HIGH FLOW NASAL CANNULA MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 86. TABLE 13 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 87. TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91. TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91. TABLE 16 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92. TABLE 17 US: CLASSIFICATION OF MEDICAL EQUIPMENT 93. TABLE 18 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 93. TABLE 19 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 94. TABLE 20 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 94. TABLE 21 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 95. TABLE 22 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 96. TABLE 23 GLOBAL STANDARDS IN HIGH FLOW NASAL CANNULA MARKET 97. TABLE 24 CERTIFICATIONS, LABELING, ECO-STANDARDS IN HIGH FLOW NASAL CANNULA MARKET 98. TABLE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 101. TABLE 26 KEY BUYING CRITERIA FOR HIGH FLOW NASAL CANNULA SYSTEMS 102. TABLE 27 HIGH FLOW NASAL CANNULA MARKET: UNMET NEEDS/END-USER EXPECTATIONS 103. TABLE 28 HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 108. TABLE 29 HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 108. TABLE 30 HIGH FLOW NASAL CANNULA SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 109. TABLE 31 HIGH FLOW NASAL CANNULA SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 110. TABLE 32 HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 111. TABLE 33 HUMIDIFIERS MARKET, BY REGION, 2024–2031 (USD MILLION) 111. TABLE 34 NASAL CANNULAS/INTERFACES MARKET, BY REGION, 2024–2031 (USD MILLION) 112. TABLE 35 BREATHING CIRCUITS/SETS MARKET, BY REGION, 2024–2031 (USD MILLION) 113. TABLE 36 HUMIDIFICATION CHAMBERS MARKET, BY REGION, 2024–2031 (USD MILLION) 114. TABLE 37 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2024–2031 (USD MILLION) 115. TABLE 38 HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION 2024–2031 (USD MILLION) 118. TABLE 39 HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, BY COUNTRY 2024–2031 (USD MILLION) 118. TABLE 40 HIGH FLOW NASAL CANNULA MARKET FOR ACUTE RESPIRATORY FAILURE, BY COUNTRY, 2024–2031 (USD MILLION) 119. TABLE 41 HIGH FLOW NASAL CANNULA MARKET FOR COPD, BY COUNTRY, 2024–2031 (USD MILLION) 120. TABLE 42 HIGH FLOW NASAL CANNULA MARKET FOR ACUTE HEART FAILURE, BY COUNTRY, 2024–2031 (USD MILLION) 121. TABLE 43 HIGH FLOW NASAL CANNULA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 122. TABLE 44 HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 125. TABLE 45 HIGH FLOW NASAL CANNULA MARKET, BY END USER, BY COUNTRY 2024–2031 (USD MILLION) 125. TABLE 46 HIGH FLOW NASAL CANNULA MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 126. TABLE 47 HIGH FLOW NASAL CANNULA MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 127. TABLE 48 HIGH FLOW NASAL CANNULA MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 128. TABLE 49 HIGH FLOW NASAL CANNULA MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 129. TABLE 50 HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE 2024–2031 (USD MILLION) 132. TABLE 51 HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, BY COUNTRY 2024–2031 (USD MILLION) 132. TABLE 52 HIGH FLOW NASAL CANNULA MARKET FOR NEONATAL & PEDIATRIC (0-17YRS), BY COUNTRY, 2024–2031 (USD MILLION) 133. TABLE 53 HIGH FLOW NASAL CANNULA MARKET FOR ADULT (18-64), BY COUNTRY, 2024–2031 (USD MILLION) 134. TABLE 54 HIGH FLOW NASAL CANNULA MARKET FOR GERIATRIC (65+), BY COUNTRY, 2024–2031 (USD MILLION) 135. TABLE 55 HIGH FLOW NASAL CANNULA MARKET, BY REGION, 2024–2031 (USD MILLION) 138. TABLE 56 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139. TABLE 57 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 140. TABLE 58 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 140. TABLE 59 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 141. TABLE 60 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 141. TABLE 61 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 142. TABLE 62 US: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 143. TABLE 63 US: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 143. TABLE 64 US: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 144. TABLE 65 US: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 144. TABLE 66 US: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 145. TABLE 67 CANADA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 146. TABLE 68 CANADA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 146. TABLE 69 CANADA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 147. TABLE 70 CANADA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 147. TABLE 71 CANADA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 148. TABLE 72 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149. TABLE 73 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 149. TABLE 74 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 150. TABLE 75 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 150. TABLE 76 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 151. TABLE 77 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 151. TABLE 78 GERMANY: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 152. TABLE 79 GERMANY: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 152. TABLE 80 GERMANY: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 153. TABLE 81 GERMANY: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 153. TABLE 82 GERMANY: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 154. TABLE 83 FRANCE: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 155. TABLE 84 FRANCE: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 155. TABLE 85 FRANCE: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 156. TABLE 86 FRANCE: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 156. TABLE 87 FRANCE: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 157. TABLE 88 UK: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 158. TABLE 89 UK: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 158. TABLE 90 UK: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 159. TABLE 91 UK: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 159. TABLE 92 UK: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 160. TABLE 93 ITALY: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 161. TABLE 94 ITALY: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 161. TABLE 95 ITALY: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 162. TABLE 96 ITALY: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 162. TABLE 97 ITALY: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 163. TABLE 98 SPAIN: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 164. TABLE 99 SPAIN: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 164. TABLE 100 SPAIN: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 165. TABLE 101 SPAIN: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 165. TABLE 102 SPAIN: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 166. TABLE 103 REST OF EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 167. TABLE 104 REST OF EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 167. TABLE 105 REST OF EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 168. TABLE 106 REST OF EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 168. TABLE 107 REST OF EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 169. TABLE 108 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170. TABLE 109 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 171. TABLE 110 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 171. TABLE 111 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 172. TABLE 112 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 172. TABLE 113 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 173. TABLE 114 JAPAN: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 174. TABLE 115 JAPAN: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 174. TABLE 116 JAPAN: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 175. TABLE 117 JAPAN: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 175. TABLE 118 JAPAN: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 176. TABLE 119 CHINA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 177. TABLE 120 CHINA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 177. TABLE 121 CHINA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 178. TABLE 122 CHINA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 178. TABLE 123 CHINA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 179. TABLE 124 INDIA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 180. TABLE 125 INDIA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 180. TABLE 126 INDIA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 181. TABLE 127 INDIA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 181. TABLE 128 INDIA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 182. TABLE 129 AUSTRALIA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 183. TABLE 130 AUSTRALIA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 183. TABLE 131 AUSTRALIA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 184. TABLE 132 AUSTRALIA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 184. TABLE 133 AUSTRALIA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 185. TABLE 134 SOUTH KOREA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 186. TABLE 135 SOUTH KOREA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 186. TABLE 136 SOUTH KOREA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 187. TABLE 137 SOUTH KOREA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 187. TABLE 138 SOUTH KOREA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 188. TABLE 139 REST OF ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 189. TABLE 140 REST OF ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 189. TABLE 141 REST OF ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 190. TABLE 142 REST OF ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 190. TABLE 143 REST OF ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 191. TABLE 144 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 191. TABLE 145 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 192. TABLE 146 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 192. TABLE 147 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 193. TABLE 148 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 193. TABLE 149 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 194. TABLE 150 BRAZIL: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 195. TABLE 151 BRAZIL: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 195. TABLE 152 BRAZIL: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 196. TABLE 153 BRAZIL: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 196. TABLE 154 BRAZIL: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 197. TABLE 155 MEXICO: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 198. TABLE 156 MEXICO: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 198. TABLE 157 MEXICO: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 199. TABLE 158 MEXICO: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 199. TABLE 159 MEXICO: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 200. TABLE 160 REST OF LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 200. TABLE 161 REST OF LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 201. TABLE 162 REST OF LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 201. TABLE 163 REST OF LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 202. TABLE 164 REST OF LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 202. TABLE 165 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203. TABLE 166 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 203. TABLE 167 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 204. TABLE 168 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 204. TABLE 169 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 205. TABLE 170 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 205. TABLE 171 GCC COUNTRIES: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 206. TABLE 172 GCC COUNTRIES: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 207. TABLE 173 GCC COUNTRIES: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 207. TABLE 174 GCC COUNTRIES: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 208. TABLE 175 GCC COUNTRIES: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 208. TABLE 176 REST OF THE MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 209. TABLE 177 REST OF THE MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 209. TABLE 178 REST OF THE MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 210. TABLE 179 REST OF THE MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 210. TABLE 180 REST OF THE MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 211. TABLE 181 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HIGH FLOW NASAL CANNULA MARKET 212. TABLE 182 HIGH FLOW NASAL CANNULA MARKET: DEGREE OF COMPETITION 214. TABLE 183 HIGH FLOW NASAL CANNULA MARKET: REGION FOOTPRINT 219. TABLE 184 HIGH FLOW NASAL CANNULA MARKET: PRODUCT FOOTPRINT 220. TABLE 185 HIGH FLOW NASAL CANNULA MARKET: PATIENT TYPE FOOTPRINT 221. TABLE 186 HIGH FLOW NASAL CANNULA MARKET: APPLICATION FOOTPRINT 222. TABLE 187 HIGH FLOW NASAL CANNULA MARKET: END-USER FOOTPRINT 223. TABLE 188 HIGH FLOW NASAL CANNULA MARKET: DETAILED LIST OF KEY STARTUPS/SMES 227. TABLE 189 HIGH FLOW NASAL CANNULA MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 227. TABLE 190 HIGH FLOW NASAL CANNULA MARKET: DEALS, JANUARY 2021– AUGUST 2026 230. TABLE 191 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW 231. TABLE 192 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCTS OFFERED 232. TABLE 193 VAPOTHERM: COMPANY OVERVIEW 235. TABLE 194 VAPOTHERM: PRODUCTS OFFERED 236. TABLE 195 VAPOTHERM: DEALS, JANUARY 2022− AUGUST 2026 237. TABLE 196 RESMED INC.: COMPANY OVERVIEW 238. TABLE 197 RESMED INC.: PRODUCTS OFFERED 239. TABLE 198 HAMILTON MEDICAL: COMPANY OVERVIEW 241. TABLE 199 HAMILTON MEDICAL: PRODUCTS OFFERED 241. TABLE 200 HAMILTON MEDICAL: EXPANSIONS, JANUARY 2022–AUGUST 2026 242. TABLE 201 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 244. TABLE 202 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 245. TABLE 203 INSPIRATION HEALTHCARE GROUP PLC: COMPANY OVERVIEW 247. TABLE 204 INSPIRATION HEALTHCARE GROUP PLC: PRODUCTS OFFERED 248. TABLE 205 MASIMO (DANAHER CORPORATION): COMPANY OVERVIEW 249. TABLE 206 MASIMO: PRODUCTS OFFERED 250. TABLE 207 MASIMO: DEALS, JANUARY 2022− AUGUST 2026 250. TABLE 208 VINCENT MEDICAL HOLDINGS LIMITED: COMPANY OVERVIEW 251. TABLE 209 VINCENT MEDICAL HOLDINGS LIMITED: PRODUCTS OFFERED 253. TABLE 210 FLEXICARE (GROUP) LIMITED: COMPANY OVERVIEW 254. TABLE 211 FLEXICARE (GROUP) LIMITED: PRODUCTS OFFERED 254. TABLE 212 MICOMME MEDICAL: COMPANY OVERVIEW 255. TABLE 213 MICOMME MEDICAL: PRODUCTS OFFERED 255. TABLE 214 BMC MEDICAL CO., LTD. COMPANY OVERVIEW 256. TABLE 215 BMC MEDICAL CO., LTD.: PRODUCTS OFFERED 256. TABLE 216 EAKIN HEALTHCARE: COMPANY OVERVIEW 257. TABLE 217 EAKIN HEALTHCARE: PRODUCTS OFFERED 257. TABLE 218 LÖWENSTEIN MEDICAL SE & CO. KG: COMPANY OVERVIEW 258. TABLE 219 LÖWENSTEIN MEDICAL SE & CO. KG: PRODUCTS OFFERED 258. TABLE 220 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW 259. TABLE 221 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: PRODUCTS OFFERED 259. TABLE 222 MEDLINE: COMPANY OVERVIEW 260. TABLE 223 MEDLINE: PRODUCTS OFFERED 260. TABLE 224 INTERSURGICAL LTD: COMPANY OVERVIEW 261. TABLE 225 RESPIRCARE MEDICAL: COMPANY OVERVIEW 262. TABLE 226 GREAT GROUP MEDICAL CO., LTD.: COMPANY OVERVIEW 263. TABLE 227 GALEMED CORPORATION: COMPANY OVERVIEW 264. TABLE 228 SILMAG S.A.: COMPANY OVERVIEW 265. TABLE 229 SALAERA LLC: COMPANY OVERVIEW 266. TABLE 230 TELESAIR, INC.: COMPANY OVERVIEW 267. TABLE 231 HEKA MEDICALS INDIA PVT. LTD.: COMPANY OVERVIEW 268. TABLE 232 BESMED HEALTH BUSINESS CORP.: COMPANY OVERVIEW 269. TABLE 233 CREATE BIOTECH CO., LTD.: COMPANY OVERVIEW 270. TABLE 234 RESEARCH ASSUMPTIONS 281. TABLE 235 RISK ASSESSMENT: HIGH FLOW NASAL CANNULA MARKET 282. FIGURE 1 HIGH FLOW NASAL CANNULA MARKET: SEGMENTS CONSIDERED 27. FIGURE 2 HIGH FLOW NASAL CANNULA MARKET: YEARS CONSIDERED 28. FIGURE 3 KEY INSIGHTS & MARKET HIGHLIGHTS 29. FIGURE 4 GLOBAL HIGH FLOW NASAL CANNULA MARKET, 2024–2031 30. FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HIGH FLOW NASAL CANNULA MARKET 30. FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF HIGH FLOW NASAL CANNULA MARKET 31. FIGURE 7 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN HIGH FLOW NASAL CANNULA MARKET, 2026 32. FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 33. FIGURE 9 RISING COPD, ASTHMA, AND RESPIRATORY FAILURE CASES TO DRIVE MARKET 34. FIGURE 10 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF HIGH FLOW NASAL CANNULA MARKET IN 2025 35. FIGURE 11 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 36. FIGURE 12 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD 37. FIGURE 13 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES 37. FIGURE 14 HIGH FLOW NASAL CANNULA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38. FIGURE 15 HIGH FLOW NASAL CANNULA MARKET: PORTER'S FIVE FORCES ANALYSIS 53. FIGURE 16 HIGH FLOW NASAL CANNULA MARKET SUPPLY CHAIN ANALYSIS 59. FIGURE 17 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE 60. FIGURE 18 HIGH FLOW NASAL CANNULA MARKET: ECOSYSTEM ANALYSIS 62. FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES IN HIGH FLOW NASAL CANNULA MARKET 65. FIGURE 20 INVESTMENT/VENTURE CAPITAL SCENARIO IN HIGH FLOW NASAL CANNULA MARKET, 2020–2023 66. FIGURE 21 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR HIGH FLOW NASAL CANNULA MARKET (JANUARY 2016–AUGUST 2026) 80. FIGURE 22 TOP PATENT APPLICANT COUNTRIES FOR HIGH FLOW NASAL CANNULA (JANUARY 2016– AUGUST 2026) 81. FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE CATEGORIES 101. FIGURE 24 KEY BUYING CRITERIA FOR HIGH FLOW NASAL CANNULA SYSTEMS 101. FIGURE 25 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET SNAPSHOT 139. FIGURE 26 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET SNAPSHOT 170. FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN HIGH FLOW NASAL CANNULA MARKET (2021−2025) 213. FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HIGH FLOW NASAL CANNULA MARKET (2025) 214. FIGURE 29 HIGH FLOW NASAL CANNULA MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 217. FIGURE 30 HIGH FLOW NASAL CANNULA MARKET: COMPANY FOOTPRINT 218. FIGURE 31 HIGH FLOW NASAL CANNULA MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 226. FIGURE 32 EV/EBITDA OF KEY VENDORS 228. FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDOR 228. FIGURE 34 HIGH FLOW NASAL CANNULA MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 229. FIGURE 35 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2026) 232. FIGURE 36 VAPOTHERM: COMPANY SNAPSHOT (2023) 236. FIGURE 37 RESMED INC.: COMPANY SNAPSHOT (2026) 239. FIGURE 38 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2025) 245. FIGURE 39 INSPIRATION HEALTHCARE GROUP PLC: COMPANY SNAPSHOT (2026) 248. FIGURE 40 VINCENT MEDICAL HOLDINGS LIMITED: COMPANY SNAPSHOT (2025) 252. FIGURE 41 RESEARCH DESIGN 271. FIGURE 42 PRIMARY SOURCES 273. FIGURE 43 BOTTOM-UP APPROACH 275. FIGURE 44 TOP-DOWN APPROACH 275. FIGURE 45 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 276. FIGURE 46 REVENUE SHARE ANALYSIS ILLUSTRATION: FISHER & PAYKEL HEALTHCARE 277. FIGURE 47 UPPLY-SIDE MARKET ESTIMATION: HIGH FLOW NASAL CANNULA MARKET (2025) 278. FIGURE 48 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 279. FIGURE 49 MARKET DATA TRIANGULATION METHODOLOGY 280.
SummaryThe high-flow nasal cannula (HFNC) market is projected to reach USD 1.44 billion by 2031 from USD 0.94 billion in 2026, at a CAGR of 8.9% during the forecast period. The HFNC market is experiencing growth due to the increasing burden of acute and chronic respiratory disorders, rising cases of acute hypoxemic respiratory failure, and growing demand for non-invasive respiratory support. HFNC provides more reliable oxygen delivery along with heated and humidified gas, improved oxygenation, reduced work of breathing, upper-airway dead-space washout, and enhanced secretion clearance. Its greater patient comfort and tolerance compared with conventional oxygen therapy and certain forms of NIV also support wider clinical adoption. In addition, the expansion of HFNC applications across intensive care units, emergency departments, post-extubation care, pre-oxygenation before intubation, perioperative management, bronchoscopy, and during breaks from NIV or CPAP is contributing to market growth. Increasing clinical acceptance and the availability of HFNC systems for neonatal, pediatric, and adult patients are further broadening its use across healthcare settings. By application, the acute respiratory failure segment is estimated to account for the largest share of the high-flow nasal cannula market. By end user, the hospitals segment is estimated to account for the largest share of the high-flow nasal cannula market. The US is expected to witness the highest CAGR in the high-flow nasal cannula market in North America. A breakdown of the primary participants (supply-side) for the high-flow nasal cannula market referred to in this report is provided below: Prominent players in the high-flow nasal cannula market include Fisher & Paykel Healthcare Limited (New Zealand), Vapotherm (US), ResMed (US), Hamilton Medical AG (Switzerland), and Drägerwerk AG & Co. KGaA (Germany). Research Coverage: Reasons to Buy the Report This report provides insights into the following pointers: Table of Contents1 INTRODUCTION 25 2 EXECUTIVE SUMMARY 29 3 PREMIUM INSIGHTS 34 4 MARKET OVERVIEW 38 5 INDUSTRY TRENDS 53 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 73 7 REGULATORY LANDSCAPE 91 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 100 9 HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT 107 10 HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION 117 11 HIGH FLOW NASAL CANNULA MARKET, BY END USER 124 12 HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE 131 13 HIGH FLOW NASAL CANNULA MARKET, BY REGION 137 14 COMPETITIVE LANDSCAPE 212 15 COMPANY PROFILES 231 16 RESEARCH METHODOLOGY 271 17 APPENDIX 284 List of Tables/GraphsTABLE 1 HIGH FLOW NASAL CANNULA MARKET: INCLUSIONS AND EXCLUSIONS 26.TABLE 2 HIGH FLOW NASAL CANNULA MARKET: CURRENT UNMET NEEDS 44. TABLE 3 HIGH FLOW NASAL CANNULA MARKET: PORTER'S FIVE FORCES ANALYSIS 53. TABLE 4 GDP PERCENTAGE CHANGE, BY KEY COUNTRIES, 2021-2030 56. TABLE 5 AVERAGE SELLING PRICE TREND OF HFNC SYSTEM, BY KEY PLAYER, 2025 (USD) 62. TABLE 6 AVERAGE PRICING TREND OF HIGH FLOW NASAL CANNULA, BY REGION, 2023–2025 (USD) 63. TABLE 7 IMPORT DATA FOR HIGH FLOW NASAL CANNULA PRODUCTS (HS CODE 9019), BY COUNTRY, 2021–2025 (USD THOUSANDS) 63. TABLE 8 EXPORT DATA FOR HIGH FLOW NASAL CANNULA PRODUCTS (HS CODE 9019), BY COUNTRY, 2021–2025 (USD THOUSANDS) 64. TABLE 9 HIGH FLOW NASAL CANNULA MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS (2026–2027) 64. TABLE 10 US ADJUSTED RECIPROCAL TARIFF RATES 68. TABLE 11 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR HIGH FLOW NASAL CANNULA 69. TABLE 12 HIGH FLOW NASAL CANNULA MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 86. TABLE 13 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 87. TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91. TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91. TABLE 16 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92. TABLE 17 US: CLASSIFICATION OF MEDICAL EQUIPMENT 93. TABLE 18 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 93. TABLE 19 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 94. TABLE 20 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 94. TABLE 21 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 95. TABLE 22 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 96. TABLE 23 GLOBAL STANDARDS IN HIGH FLOW NASAL CANNULA MARKET 97. TABLE 24 CERTIFICATIONS, LABELING, ECO-STANDARDS IN HIGH FLOW NASAL CANNULA MARKET 98. TABLE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 101. TABLE 26 KEY BUYING CRITERIA FOR HIGH FLOW NASAL CANNULA SYSTEMS 102. TABLE 27 HIGH FLOW NASAL CANNULA MARKET: UNMET NEEDS/END-USER EXPECTATIONS 103. TABLE 28 HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 108. TABLE 29 HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 108. TABLE 30 HIGH FLOW NASAL CANNULA SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 109. TABLE 31 HIGH FLOW NASAL CANNULA SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 110. TABLE 32 HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 111. TABLE 33 HUMIDIFIERS MARKET, BY REGION, 2024–2031 (USD MILLION) 111. TABLE 34 NASAL CANNULAS/INTERFACES MARKET, BY REGION, 2024–2031 (USD MILLION) 112. TABLE 35 BREATHING CIRCUITS/SETS MARKET, BY REGION, 2024–2031 (USD MILLION) 113. TABLE 36 HUMIDIFICATION CHAMBERS MARKET, BY REGION, 2024–2031 (USD MILLION) 114. TABLE 37 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2024–2031 (USD MILLION) 115. TABLE 38 HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION 2024–2031 (USD MILLION) 118. TABLE 39 HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, BY COUNTRY 2024–2031 (USD MILLION) 118. TABLE 40 HIGH FLOW NASAL CANNULA MARKET FOR ACUTE RESPIRATORY FAILURE, BY COUNTRY, 2024–2031 (USD MILLION) 119. TABLE 41 HIGH FLOW NASAL CANNULA MARKET FOR COPD, BY COUNTRY, 2024–2031 (USD MILLION) 120. TABLE 42 HIGH FLOW NASAL CANNULA MARKET FOR ACUTE HEART FAILURE, BY COUNTRY, 2024–2031 (USD MILLION) 121. TABLE 43 HIGH FLOW NASAL CANNULA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 122. TABLE 44 HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 125. TABLE 45 HIGH FLOW NASAL CANNULA MARKET, BY END USER, BY COUNTRY 2024–2031 (USD MILLION) 125. TABLE 46 HIGH FLOW NASAL CANNULA MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 126. TABLE 47 HIGH FLOW NASAL CANNULA MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 127. TABLE 48 HIGH FLOW NASAL CANNULA MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 128. TABLE 49 HIGH FLOW NASAL CANNULA MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 129. TABLE 50 HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE 2024–2031 (USD MILLION) 132. TABLE 51 HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, BY COUNTRY 2024–2031 (USD MILLION) 132. TABLE 52 HIGH FLOW NASAL CANNULA MARKET FOR NEONATAL & PEDIATRIC (0-17YRS), BY COUNTRY, 2024–2031 (USD MILLION) 133. TABLE 53 HIGH FLOW NASAL CANNULA MARKET FOR ADULT (18-64), BY COUNTRY, 2024–2031 (USD MILLION) 134. TABLE 54 HIGH FLOW NASAL CANNULA MARKET FOR GERIATRIC (65+), BY COUNTRY, 2024–2031 (USD MILLION) 135. TABLE 55 HIGH FLOW NASAL CANNULA MARKET, BY REGION, 2024–2031 (USD MILLION) 138. TABLE 56 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139. TABLE 57 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 140. TABLE 58 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 140. TABLE 59 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 141. TABLE 60 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 141. TABLE 61 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 142. TABLE 62 US: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 143. TABLE 63 US: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 143. TABLE 64 US: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 144. TABLE 65 US: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 144. TABLE 66 US: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 145. TABLE 67 CANADA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 146. TABLE 68 CANADA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 146. TABLE 69 CANADA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 147. TABLE 70 CANADA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 147. TABLE 71 CANADA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 148. TABLE 72 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149. TABLE 73 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 149. TABLE 74 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 150. TABLE 75 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 150. TABLE 76 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 151. TABLE 77 EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 151. TABLE 78 GERMANY: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 152. TABLE 79 GERMANY: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 152. TABLE 80 GERMANY: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 153. TABLE 81 GERMANY: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 153. TABLE 82 GERMANY: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 154. TABLE 83 FRANCE: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 155. TABLE 84 FRANCE: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 155. TABLE 85 FRANCE: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 156. TABLE 86 FRANCE: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 156. TABLE 87 FRANCE: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 157. TABLE 88 UK: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 158. TABLE 89 UK: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 158. TABLE 90 UK: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 159. TABLE 91 UK: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 159. TABLE 92 UK: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 160. TABLE 93 ITALY: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 161. TABLE 94 ITALY: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 161. TABLE 95 ITALY: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 162. TABLE 96 ITALY: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 162. TABLE 97 ITALY: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 163. TABLE 98 SPAIN: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 164. TABLE 99 SPAIN: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 164. TABLE 100 SPAIN: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 165. TABLE 101 SPAIN: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 165. TABLE 102 SPAIN: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 166. TABLE 103 REST OF EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 167. TABLE 104 REST OF EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 167. TABLE 105 REST OF EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 168. TABLE 106 REST OF EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 168. TABLE 107 REST OF EUROPE: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 169. TABLE 108 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170. TABLE 109 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 171. TABLE 110 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 171. TABLE 111 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 172. TABLE 112 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 172. TABLE 113 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 173. TABLE 114 JAPAN: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 174. TABLE 115 JAPAN: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 174. TABLE 116 JAPAN: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 175. TABLE 117 JAPAN: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 175. TABLE 118 JAPAN: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 176. TABLE 119 CHINA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 177. TABLE 120 CHINA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 177. TABLE 121 CHINA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 178. TABLE 122 CHINA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 178. TABLE 123 CHINA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 179. TABLE 124 INDIA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 180. TABLE 125 INDIA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 180. TABLE 126 INDIA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 181. TABLE 127 INDIA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 181. TABLE 128 INDIA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 182. TABLE 129 AUSTRALIA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 183. TABLE 130 AUSTRALIA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 183. TABLE 131 AUSTRALIA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 184. TABLE 132 AUSTRALIA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 184. TABLE 133 AUSTRALIA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 185. TABLE 134 SOUTH KOREA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 186. TABLE 135 SOUTH KOREA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 186. TABLE 136 SOUTH KOREA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 187. TABLE 137 SOUTH KOREA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 187. TABLE 138 SOUTH KOREA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 188. TABLE 139 REST OF ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 189. TABLE 140 REST OF ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 189. TABLE 141 REST OF ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 190. TABLE 142 REST OF ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 190. TABLE 143 REST OF ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 191. TABLE 144 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 191. TABLE 145 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 192. TABLE 146 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 192. TABLE 147 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 193. TABLE 148 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 193. TABLE 149 LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 194. TABLE 150 BRAZIL: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 195. TABLE 151 BRAZIL: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 195. TABLE 152 BRAZIL: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 196. TABLE 153 BRAZIL: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 196. TABLE 154 BRAZIL: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 197. TABLE 155 MEXICO: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 198. TABLE 156 MEXICO: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 198. TABLE 157 MEXICO: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 199. TABLE 158 MEXICO: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 199. TABLE 159 MEXICO: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 200. TABLE 160 REST OF LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 200. TABLE 161 REST OF LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 201. TABLE 162 REST OF LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 201. TABLE 163 REST OF LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 202. TABLE 164 REST OF LATIN AMERICA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 202. TABLE 165 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203. TABLE 166 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 203. TABLE 167 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 204. TABLE 168 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 204. TABLE 169 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 205. TABLE 170 MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 205. TABLE 171 GCC COUNTRIES: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 206. TABLE 172 GCC COUNTRIES: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 207. TABLE 173 GCC COUNTRIES: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 207. TABLE 174 GCC COUNTRIES: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 208. TABLE 175 GCC COUNTRIES: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 208. TABLE 176 REST OF THE MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 209. TABLE 177 REST OF THE MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY CONSUMABLES AND ACCESSORIES, 2024–2031 (USD MILLION) 209. TABLE 178 REST OF THE MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY PATIENT TYPE, 2024–2031 (USD MILLION) 210. TABLE 179 REST OF THE MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 210. TABLE 180 REST OF THE MIDDLE EAST & AFRICA: HIGH FLOW NASAL CANNULA MARKET, BY END USER, 2024–2031 (USD MILLION) 211. TABLE 181 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HIGH FLOW NASAL CANNULA MARKET 212. TABLE 182 HIGH FLOW NASAL CANNULA MARKET: DEGREE OF COMPETITION 214. TABLE 183 HIGH FLOW NASAL CANNULA MARKET: REGION FOOTPRINT 219. TABLE 184 HIGH FLOW NASAL CANNULA MARKET: PRODUCT FOOTPRINT 220. TABLE 185 HIGH FLOW NASAL CANNULA MARKET: PATIENT TYPE FOOTPRINT 221. TABLE 186 HIGH FLOW NASAL CANNULA MARKET: APPLICATION FOOTPRINT 222. TABLE 187 HIGH FLOW NASAL CANNULA MARKET: END-USER FOOTPRINT 223. TABLE 188 HIGH FLOW NASAL CANNULA MARKET: DETAILED LIST OF KEY STARTUPS/SMES 227. TABLE 189 HIGH FLOW NASAL CANNULA MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 227. TABLE 190 HIGH FLOW NASAL CANNULA MARKET: DEALS, JANUARY 2021– AUGUST 2026 230. TABLE 191 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW 231. TABLE 192 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCTS OFFERED 232. TABLE 193 VAPOTHERM: COMPANY OVERVIEW 235. TABLE 194 VAPOTHERM: PRODUCTS OFFERED 236. TABLE 195 VAPOTHERM: DEALS, JANUARY 2022− AUGUST 2026 237. TABLE 196 RESMED INC.: COMPANY OVERVIEW 238. TABLE 197 RESMED INC.: PRODUCTS OFFERED 239. TABLE 198 HAMILTON MEDICAL: COMPANY OVERVIEW 241. TABLE 199 HAMILTON MEDICAL: PRODUCTS OFFERED 241. TABLE 200 HAMILTON MEDICAL: EXPANSIONS, JANUARY 2022–AUGUST 2026 242. TABLE 201 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 244. TABLE 202 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 245. TABLE 203 INSPIRATION HEALTHCARE GROUP PLC: COMPANY OVERVIEW 247. TABLE 204 INSPIRATION HEALTHCARE GROUP PLC: PRODUCTS OFFERED 248. TABLE 205 MASIMO (DANAHER CORPORATION): COMPANY OVERVIEW 249. TABLE 206 MASIMO: PRODUCTS OFFERED 250. TABLE 207 MASIMO: DEALS, JANUARY 2022− AUGUST 2026 250. TABLE 208 VINCENT MEDICAL HOLDINGS LIMITED: COMPANY OVERVIEW 251. TABLE 209 VINCENT MEDICAL HOLDINGS LIMITED: PRODUCTS OFFERED 253. TABLE 210 FLEXICARE (GROUP) LIMITED: COMPANY OVERVIEW 254. TABLE 211 FLEXICARE (GROUP) LIMITED: PRODUCTS OFFERED 254. TABLE 212 MICOMME MEDICAL: COMPANY OVERVIEW 255. TABLE 213 MICOMME MEDICAL: PRODUCTS OFFERED 255. TABLE 214 BMC MEDICAL CO., LTD. COMPANY OVERVIEW 256. TABLE 215 BMC MEDICAL CO., LTD.: PRODUCTS OFFERED 256. TABLE 216 EAKIN HEALTHCARE: COMPANY OVERVIEW 257. TABLE 217 EAKIN HEALTHCARE: PRODUCTS OFFERED 257. TABLE 218 LÖWENSTEIN MEDICAL SE & CO. KG: COMPANY OVERVIEW 258. TABLE 219 LÖWENSTEIN MEDICAL SE & CO. KG: PRODUCTS OFFERED 258. TABLE 220 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW 259. TABLE 221 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: PRODUCTS OFFERED 259. TABLE 222 MEDLINE: COMPANY OVERVIEW 260. TABLE 223 MEDLINE: PRODUCTS OFFERED 260. TABLE 224 INTERSURGICAL LTD: COMPANY OVERVIEW 261. TABLE 225 RESPIRCARE MEDICAL: COMPANY OVERVIEW 262. TABLE 226 GREAT GROUP MEDICAL CO., LTD.: COMPANY OVERVIEW 263. TABLE 227 GALEMED CORPORATION: COMPANY OVERVIEW 264. TABLE 228 SILMAG S.A.: COMPANY OVERVIEW 265. TABLE 229 SALAERA LLC: COMPANY OVERVIEW 266. TABLE 230 TELESAIR, INC.: COMPANY OVERVIEW 267. TABLE 231 HEKA MEDICALS INDIA PVT. LTD.: COMPANY OVERVIEW 268. TABLE 232 BESMED HEALTH BUSINESS CORP.: COMPANY OVERVIEW 269. TABLE 233 CREATE BIOTECH CO., LTD.: COMPANY OVERVIEW 270. TABLE 234 RESEARCH ASSUMPTIONS 281. TABLE 235 RISK ASSESSMENT: HIGH FLOW NASAL CANNULA MARKET 282. FIGURE 1 HIGH FLOW NASAL CANNULA MARKET: SEGMENTS CONSIDERED 27. FIGURE 2 HIGH FLOW NASAL CANNULA MARKET: YEARS CONSIDERED 28. FIGURE 3 KEY INSIGHTS & MARKET HIGHLIGHTS 29. FIGURE 4 GLOBAL HIGH FLOW NASAL CANNULA MARKET, 2024–2031 30. FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HIGH FLOW NASAL CANNULA MARKET 30. FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF HIGH FLOW NASAL CANNULA MARKET 31. FIGURE 7 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN HIGH FLOW NASAL CANNULA MARKET, 2026 32. FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 33. FIGURE 9 RISING COPD, ASTHMA, AND RESPIRATORY FAILURE CASES TO DRIVE MARKET 34. FIGURE 10 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF HIGH FLOW NASAL CANNULA MARKET IN 2025 35. FIGURE 11 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 36. FIGURE 12 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD 37. FIGURE 13 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES 37. FIGURE 14 HIGH FLOW NASAL CANNULA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38. FIGURE 15 HIGH FLOW NASAL CANNULA MARKET: PORTER'S FIVE FORCES ANALYSIS 53. FIGURE 16 HIGH FLOW NASAL CANNULA MARKET SUPPLY CHAIN ANALYSIS 59. FIGURE 17 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE 60. FIGURE 18 HIGH FLOW NASAL CANNULA MARKET: ECOSYSTEM ANALYSIS 62. FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES IN HIGH FLOW NASAL CANNULA MARKET 65. FIGURE 20 INVESTMENT/VENTURE CAPITAL SCENARIO IN HIGH FLOW NASAL CANNULA MARKET, 2020–2023 66. FIGURE 21 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR HIGH FLOW NASAL CANNULA MARKET (JANUARY 2016–AUGUST 2026) 80. FIGURE 22 TOP PATENT APPLICANT COUNTRIES FOR HIGH FLOW NASAL CANNULA (JANUARY 2016– AUGUST 2026) 81. FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE CATEGORIES 101. FIGURE 24 KEY BUYING CRITERIA FOR HIGH FLOW NASAL CANNULA SYSTEMS 101. FIGURE 25 NORTH AMERICA: HIGH FLOW NASAL CANNULA MARKET SNAPSHOT 139. FIGURE 26 ASIA PACIFIC: HIGH FLOW NASAL CANNULA MARKET SNAPSHOT 170. FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN HIGH FLOW NASAL CANNULA MARKET (2021−2025) 213. FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HIGH FLOW NASAL CANNULA MARKET (2025) 214. FIGURE 29 HIGH FLOW NASAL CANNULA MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 217. FIGURE 30 HIGH FLOW NASAL CANNULA MARKET: COMPANY FOOTPRINT 218. FIGURE 31 HIGH FLOW NASAL CANNULA MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 226. FIGURE 32 EV/EBITDA OF KEY VENDORS 228. FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDOR 228. FIGURE 34 HIGH FLOW NASAL CANNULA MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 229. FIGURE 35 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2026) 232. FIGURE 36 VAPOTHERM: COMPANY SNAPSHOT (2023) 236. FIGURE 37 RESMED INC.: COMPANY SNAPSHOT (2026) 239. FIGURE 38 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2025) 245. FIGURE 39 INSPIRATION HEALTHCARE GROUP PLC: COMPANY SNAPSHOT (2026) 248. FIGURE 40 VINCENT MEDICAL HOLDINGS LIMITED: COMPANY SNAPSHOT (2025) 252. FIGURE 41 RESEARCH DESIGN 271. FIGURE 42 PRIMARY SOURCES 273. FIGURE 43 BOTTOM-UP APPROACH 275. FIGURE 44 TOP-DOWN APPROACH 275. FIGURE 45 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 276. FIGURE 46 REVENUE SHARE ANALYSIS ILLUSTRATION: FISHER & PAYKEL HEALTHCARE 277. FIGURE 47 UPPLY-SIDE MARKET ESTIMATION: HIGH FLOW NASAL CANNULA MARKET (2025) 278. FIGURE 48 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 279. FIGURE 49 MARKET DATA TRIANGULATION METHODOLOGY 280.
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポートMarketsandMarkets社の Medical Devices分野 での最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|